Jumei Shi

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Venues

Cancer medicine

Journal of biomedical science

Leukemia

Acta biochimica et biophysica Sinica

This page only lists publications with an associated author ORCID identifier.

Publications

Shuaikang Chang, Wenqin Xiao, Yongsheng Xie, Zhijian Xu, Bo Li, Guanli Wang, Ke Hu, Yong Zhang, Jinfeng Zhou, Dongliang Song, Huabin Zhu, Xiaosong Wu, Yumeng Lu, Jumei Shi, Weiliang Zhu
TI17, a novel compound, exerts anti-MM activity by impairing Trip13 function of DSBs repair and enhancing DNA damage. Cancer medicine (2023)
Li Xu, Yingcong Wang, Guanli Wang, Shushan Guo, Dandan Yu, Qilin Feng, Ke Hu, Gege Chen, Bo Li, Zhijian Xu, Xinyan Jia, Yumeng Lu, Hui Zhang, Xuejie Gao, Shuaikang Chang, Huaping Wang, Xiaosong Wu, Dongliang Song, Guang Yang, Huabin Zhu, Jinfeng Zhou, Fenghuang Zhan, Jianming Zhu, Jumei Shi
Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma. Leukemia (2023)
Yingcong Wang, Sanfeng Dong, Ke Hu, Li Xu, Qilin Feng, Bo Li, Guangli Wang, Gege Chen, Bibo Zhang, Xinyan Jia, Zhijian Xu, Xuejie Gao, Hui Zhang, Yongsheng Xie, Meiling Lu, Shuaikang Chang, Dongliang Song, Xiaosong Wu, Qi Jia, Huabin Zhu, Jinfeng Zhou, Weiliang Zhu, Jumei Shi
The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway. Journal of translational medicine 21 (1) (2023)
Yongsheng Xie, Yingcong Wang, Zhijian Xu, Yumeng Lu, Dongliang Song, Lu Gao, Dandan Yu, Bo Li, Gege Chen, Hui Zhang, Qilin Feng, Yong Zhang, Ke Hu, Cheng Huang, Yu Peng, Xiaosong Wu, Zhiyong Mao, Jimin Shao, Weiliang Zhu, Jumei Shi
Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma. Journal of biomedical science 29 (1) (2022)
Xuejie Gao, Bo Li, Anqi Ye, Houcai Wang, Yongsheng Xie, Dandan Yu, Zhijian Xu, Bingqing Shi, Hui Zhang, Qilin Feng, Ke Hu, Yong Zhang, Cheng Huang, Guang Yang, Jumei Shi, Weiliang Zhu
A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-κB pathway. Cancer cell international 21 (1) (2021)
Ruye Ma, Dandan Yu, Yu Peng, Hongfei Yi, Yingcong Wang, Taofang Cheng, Bingqing Shi, Guang Yang, Weiming Lai, Xiaosong Wu, Ye Lu, Jumei Shi
Resveratrol induces AMPK and mTOR signaling inhibition-mediated autophagy and apoptosis in multiple myeloma cells. Acta biochimica et biophysica Sinica 53 (6) (2021)
Yi Xie, Mengyu Jia, Jumei Shi, Yi Tao
Inferior prognosis of gastric involvement in patients with gastrointestinal Burkitt Lymphoma. Cancer medicine 9 (9) (2020)
Gaomei Chang, Wenqin Xiao, Zhijian Xu, Dandan Yu, Bo Li, Yong Zhang, Xi Sun, Yongsheng Xie, Shuaikang Chang, Lu Gao, Gege Chen, Liangning Hu, Bingqian Xie, Bojie Dai, Jianming Zhu, Jumei Shi
Pterostilbene Induces Cell Apoptosis and Cell Cycle Arrest in T-Cell Leukemia/Lymphoma by Suppressing the ERK1/2 Pathway. BioMed research international 2017 (2017)

Jumei Shi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jumei Shi